Generic drug from Gaviscon
Therapeutic class: Gastro-Entero-Hepatology
active ingredients: Sodium alginate (E401), [Sodium bicarbonate (E550i), 651]
Bottle of 250 ml
Symptomatic treatment of gastroesophageal reflux.
Dosage ALGINATE / BICARB SODIUM BGR 250 mg / 133.5 mg / 5 mL Oral suspension 250 ml bottle
2 measuring spoons (ie 10 ml) 3 times a day, after the 3 main meals and possibly evening at bedtime.
This dosage may be doubled in case of severe reflux or esophageal inflammation.
Shake the bottle well before use.
Hypersensitivity to any of the components of the oral suspension.
Side effects Alginate / Bicarb Sodium Bgr
Related to calcium carbonate:
· Possible constipation, which is exceptional thanks to the presence of alginate.
· In prolonged use, possible hypercalcemia with risk of nephrolithiasis and renal failure.
Reporting of suspected adverse reactions
The reporting of suspected adverse reactions after authorization of the drug is important. It allows continuous monitoring of the benefit / risk ratio of the drug. Healthcare professionals declare any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (Ansm) and the network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr